Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Genus Pharmaceuticals Limited, T/A Genus Pharmaceuticals, Linthwaite, Huddersfield, HD7 5QH, UK
Eldisine Powder for Solution for Injection 5.0 mg.
| Pharmaceutical Form |
|---|
|
Powder for Solution for Injection. A clear glass vial containing a lyophilised plug of white crystalline powder. |
Eldisine Powder 5mg contains 5mg vindesine sulphate per 5ml when reconstituted.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Vindesine |
Vindesine is an antineoplastic agent derived from vinblastine, like the other vinca alkaloids it causes mitotic arrest in metaphase by binding to microtubular protein. |
| List of Excipients |
|---|
|
Mannitol |
Single vials comprising Type I glass each with a rubber stopper, an aluminium sealing ring and a polypropylene cap.
Genus Pharmaceuticals Limited, T/A Genus Pharmaceuticals, Linthwaite, Huddersfield, HD7 5QH, UK
PL 06831/0117
17/03/2009
| Drug | Countries | |
|---|---|---|
| ELDISINE | Austria, France, Italy, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
